Astera Labs (NASDAQ:ALAB) General Counsel Sells $600,306.20 in Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) General Counsel Philip Mazzara sold 4,849 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.80, for a total transaction of $600,306.20. Following the sale, the general counsel owned 138,084 shares in the company, valued at approximately $17,094,799.20. This trade represents a 3.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Astera Labs Stock Performance

Shares of ALAB opened at $129.68 on Friday. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The company has a market capitalization of $21.90 billion, a PE ratio of 106.30, a price-to-earnings-growth ratio of 2.55 and a beta of 1.50. The stock has a fifty day moving average of $160.40 and a two-hundred day moving average of $174.33.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The business’s revenue was up 91.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Zacks highlights rising AI connectivity demand and Astera’s expansion of NVLink and Scorpio product lines, framing a multiyear market opportunity that could support revenue growth. ALAB Rides on Strong Connectivity Demand
  • Positive Sentiment: Seeking Alpha notes strong fundamentals: revenue more than doubled YoY, very healthy free cash flow margins (>30%), roughly $1.19B cash and no debt — giving Astera flexibility to invest or absorb near‑term headwinds. The Great Astera Labs Reset
  • Positive Sentiment: Recent quarterly results beat expectations (EPS and revenue) and management set Q1 2026 guidance; continued demand for high‑speed interconnects supports the growth narrative. Earnings & Guidance
  • Neutral Sentiment: Reported short-interest data is effectively immaterial/odd (reported as zero), so short‑pressure does not explain intraday moves — it’s a non‑factor for current trading dynamics. Short Interest Report
  • Negative Sentiment: CEO sale: Jitendra Mohan sold 94,971 shares at ~$123.81 (~$11.8M), trimming his stake by ~6.14% — a sizeable single‑day sale that can be viewed negatively by investors. CEO Form 4
  • Negative Sentiment: COO sale: Sanjay Gajendra sold 94,971 shares at ~$123.81 (~$11.8M), reducing his holding by ~5.84% — another large insider disposition on the same date that amplifies concern. COO Form 4
  • Negative Sentiment: CFO sale: Michael Truett Tate sold 12,001 shares at ~$123.81 (~$1.49M), lowering his stake by ~5.88% — adds to the cluster of senior‑level selling. CFO Form 4
  • Negative Sentiment: General Counsel sale: Philip Mazzara sold 4,849 shares at ~$123.80 (~$600k), a smaller but concurrent insider reduction — multiple senior officers selling the same day increases perceived signal of liquidity taking or diversification. GC Form 4

Hedge Funds Weigh In On Astera Labs

A number of hedge funds have recently made changes to their positions in the business. Royal Bank of Canada boosted its position in Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC raised its position in Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after purchasing an additional 7,756 shares during the period. Empowered Funds LLC lifted its stake in shares of Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares in the last quarter. CWM LLC boosted its position in shares of Astera Labs by 79.3% in the second quarter. CWM LLC now owns 6,734 shares of the company’s stock worth $609,000 after buying an additional 2,979 shares during the period. Finally, Harbour Investments Inc. boosted its position in shares of Astera Labs by 207.7% in the second quarter. Harbour Investments Inc. now owns 2,446 shares of the company’s stock worth $221,000 after buying an additional 1,651 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ALAB. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Royal Bank Of Canada started coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target for the company. BNP Paribas Exane started coverage on shares of Astera Labs in a report on Thursday, November 20th. They issued an “outperform” rating on the stock. Needham & Company LLC boosted their price objective on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $192.89.

View Our Latest Analysis on ALAB

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.